Peter Jakubicka

CEO

3 past transactions

SuperScale

Series A in 2024
SuperScale is a growth platform focused on profitably scaling games and blockchain applications. It provides essential services to game developers and publishers, including scalability and concept assessments, paid user acquisition, creative production, application store optimization, and free-to-play game design. By offering these comprehensive solutions, SuperScale helps clients successfully launch their flagship mobile titles and maximize their potential in the market.

SuperScale

Series A in 2023
SuperScale is a growth platform focused on profitably scaling games and blockchain applications. It provides essential services to game developers and publishers, including scalability and concept assessments, paid user acquisition, creative production, application store optimization, and free-to-play game design. By offering these comprehensive solutions, SuperScale helps clients successfully launch their flagship mobile titles and maximize their potential in the market.

Tachyum

Series B in 2021
Tachyum Inc., founded in 2016 and based in Santa Clara, California, specializes in the development and manufacturing of advanced processing chips, notably the Prodigy series, which includes models such as the T216, T432, T864, and TI6128. The company's products are designed to meet the demands of data centers, artificial intelligence, and high-performance computing workloads. Tachyum's Prodigy processors aim to transform hyper-scale data centers into low-cost, energy-efficient universal computing centers, significantly reducing operational costs—by as much as four times—thereby saving customers billions annually. The solutions provided by Tachyum enhance performance and power efficiency while addressing the complex challenges associated with big data analytics, deep learning, and large-scale computing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.